Susan G. Komen is marking a significant milestone in the effort to improve care and outcomes for people facing inflammatory ...

Susan G. Komen®, the world’s leading breast cancer organization, announced a major step forward in its work to detect, treat and better understand the prevalence of Inflammatory Breast Cancer (IBC).

Colorectal cancer is "on the rise in younger people for reasons that we don't quite understand,” says Despina Siolas, MD, an ...

For many women, especially Black women in the U.S., breast cancer symptoms don’t follow the textbook. And that’s a problem, because early detection can mean the difference between life and death. Here ...

New results from a clinical trial show that existing drugs can successfully kill dormant breast cancer cells, thereby reducing lifetime risk of recurrence.

Breast cancer is the most common cancer diagnosed among American women, accounting for about 30 percent of all new cases ...

Although the growing incidence of Breast cancer is scary, there is still hope as it is one of the most treatable cancers.

When people think of breast cancer, they often picture obvious warning signs like lumps or noticeable changes in breast shape.But not all symptoms are that clear-cut. In fact, some of the earliest ...

Inflammatory breast cancer treatment is challenging, requiring patients to advocate for clear information and involvement in decisions. Medical professionals may not fully understand or address ...